Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer (2022)

First Author: Howard D
Attributed to:  Swansea University – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2022.1014280

PubMed Identifier: 36505806

Publication URI: http://europepmc.org/abstract/MED/36505806

Type: Journal Article/Review

Parent Publication: Frontiers in Oncology

ISSN: 2234-943X